AYTU BIOPHARMA, INC (AYTU) Shareholders’ equity 2016–2025
AYTU BIOPHARMA, INC (AYTU) shareholders’ equity at each fiscal year-end, per SEC filings.
$19.0MFY2025 · since FY2016: $10.1M → $19.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.0M | -31.6% |
| FY2024 | $27.7M | -29.6% |
| FY2023 | $39.4M | -11.2% |
| FY2022 | $44.3M | -67.8% |
| FY2021 | $137.6M | +44.8% |
| FY2020 | $95.0M | +1240.5% |
| FY2019 | $7.1M | -47.2% |
| FY2018 | $13.4M | +235.6% |
| FY2017 | $4.0M | -60.3% |
| FY2016 | $10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice